Sofia‐Iris Bibli
Impact in
- Biochemistry top 0.5%
- Sulfur Compounds in Biology
- Eicosanoids and Hypertension Pharmacology
- Physiology top 5%
- Nitric Oxide and Endothelin Effects
- Smoking Behavior and Cessation
Papers in
- Biochemistry 18
- Sulfur Compounds in Biology 13
- Eicosanoids and Hypertension Pharmacology 8
- Physiology 12
- Nitric Oxide and Endothelin Effects 7
- Co-authors
- Andreas Papapetropoulos (15 shared papers)Ingrid Fleming (18 shared papers)Csaba Szabó (7 shared papers)Antonia Katsouda (4 shared papers)Sven Zukunft (6 shared papers)Ioanna Andreadou (9 shared papers)Stavros Topouzis (2 shared papers)Efstathios K. Iliodromitis (8 shared papers)
- Journals
- Redox Biology (6 papers)Basic Research in Cardiology (3 papers)Cell Metabolism (3 papers)Cardiovascular Research (3 papers)Pharmacological Research (2 papers)
- Partner nations
- GermanyGreeceUnited States
In The Last Decade
Sofia‐Iris Bibli
49 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 106
- Biochemistry 698
- Physiology 390
- Cancer Research 201
- Endocrine and Autonomic Systems 92
- Cardiology and Cardiovascular Medicine 292
Countries citing papers authored by Sofia‐Iris Bibli
This map shows the geographic impact of Sofia‐Iris Bibli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia‐Iris Bibli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia‐Iris Bibli more than expected).
Fields of papers citing papers by Sofia‐Iris Bibli
This network shows the impact of papers produced by Sofia‐Iris Bibli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia‐Iris Bibli. The network helps show where Sofia‐Iris Bibli may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofia‐Iris Bibli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 240 | |
| 2 | 2018 | 159 | |
| 3 | 2017 | 143 | |
| 4 | 2018 | 131 | |
| 5 | 2018 | 128 | |
| 6 | 2019 | 108 | |
| 7 | 2016 | 104 | |
| 8 | 2014 | 100 | |
| 9 | 2020 | 92 | |
| 10 | 2015 | 71 | |
| 11 | 2019 | 66 | |
| 12 | 2018 | 61 | |
| 13 | 2020 | 56 | |
| 14 | 2019 | 55 | |
| 15 | 2019 | 48 | |
| 16 | 2019 | 45 | |
| 17 | 2014 | 43 | |
| 18 | 2021 | 41 | |
| 19 | 2018 | 36 | |
| 20 | 2024 | 35 |
About Sofia‐Iris Bibli
Sofia‐Iris Bibli is a scholar working on Biochemistry, Physiology, Pathology and Forensic Medicine, Cancer Research and Molecular Biology, having authored 49 papers that have together received 2.2k indexed citations. Recurring topics across this work include Sulfur Compounds in Biology (13 papers), Eicosanoids and Hypertension Pharmacology (8 papers), Nitric Oxide and Endothelin Effects (7 papers), Cardiac Ischemia and Reperfusion (7 papers), Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers), MicroRNA in disease regulation (3 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Biochemistry (698 citations), Physiology (390 citations), Cancer Research (201 citations), Endocrine and Autonomic Systems (92 citations) and Cardiology and Cardiovascular Medicine (292 citations). Sofia‐Iris Bibli has collaborated with scholars based in Germany, Greece and United States. Frequent co-authors include Andreas Papapetropoulos, Ingrid Fleming, Csaba Szabó, Antonia Katsouda, Sven Zukunft, Ioanna Andreadou, Stavros Topouzis, Efstathios K. Iliodromitis, Anastasia Pyriochou and Jiong Hu. Their work appears in journals such as Redox Biology, Basic Research in Cardiology, Cell Metabolism, Cardiovascular Research and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.